Artal Participations S.a r.l 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 5:08 pm Purchase | 2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 3,568,842 9.900% | 2,105,013 (+143.80%) | Filing |
| 2023-02-10 7:41 pm Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 1,463,829 7.200% | 1,113,829 (+318.24%) | Filing |
| 2022-02-11 06:28 am Purchase | 2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 350,000 5.600% | 350,000 (New Position) | Filing |